Imricor Medical Systems said the US Food and Drug Administration has completed its review of module three of the company's premarket approval submission, which covers non-clinical bench ...
The implantable device, which first gained U.S. Food and Drug Administration (FDA) approval in April, was designed to provide high-quality patient care and simplify electrophysiology workflows. It ...
BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results